M
Live / Registered — Registered (as of 29 Jan 2019)
What this means for you
Registered since 29 Jan 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79225539
- Registration number
- 5663397
- Mark type
- Design + words
- Filed
- 01 Dec 2017
- Published for opposition
- 13 Nov 2018
- Registered
- 29 Jan 2019
- Attorney of record
- Pina Campagna
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary products, namely, preparations for the treatment of gut dysbiosis related diseases; food supplements for humans and animals; dietary supplements for humans and animals, namely, nutritional supplements; dietary supplements for humans and animals, namely, dietetic food and beverages for medical or veterinary use; chemical preparations for medical or pharmaceutical use, namely, for the treatment of gut dysbiosis related diseases; chemical preparations for pharmaceutical or medical use, namely, microbiotherapy preparations for the repair of intestinal microbiome; bacteriological preparations for medical or veterinary use; bacterial preparations for medical or veterinary use; biological preparations for medical or veterinary use, namely for the treatment of gut dysbiosis related diseases; culture media for bacteriology; chemico-pharmaceutical preparations, namely, for the treatment of gut dysbiosis related diseases; microbiotherapy preparations for medical use for the repair of intestinal microbiome
- Class 041 — Education and entertainment services: [ Education, namely classes, seminars, workshops, in the field of, microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; training in the field of microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; training, namely, organization and conducting of colloquiums, conferences, congresses, seminars in the field of microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; education, namely, arranging of exhibitions for educational purposes; training, namely, arranging and conducting workshops in the field of microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; training in the field of microbiotherapy ]
- Class 042 — Scientific and technological services: [ Evaluations and assessments in the fields of science and technology provided by engineers; scientific and technical research in the field of biomarkers, nutrition, microbiotherapy, bacteriotherapy, and therapies meant to have an effect on the gut microbiota functions; research and development of new products for others; technical project studies namely, engineering services in the nature of technical project planning for the manufacture, control and traceability of pharmaceutical products having an effect on gut microbiota or biomarkers aiming at characterizing the gut microbiota; chemical analysis; chemistry services namely, laboratory research in the field of chemistry; conducting clinical trials for others; surveying engineering work; scientific laboratory services; research in biology, bacteriology, chemistry and physics; scientific research in the field of microbiotherapy ]
Owner
- MAAT PHARMA, Lyon, FR
- MAAT PHARMA, FR
- MAAT PHARMA, FR
Prosecution history
- 25 Mar 2026 — TEAS PETITION TO DIRECTOR RECEIVED
- 19 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Mar 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 19 Mar 2026 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 19 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Mar 2026 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 18 Dec 2025 — PROOF OF USE INTERIM ACTION ISSUED
- 11 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 10 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Dec 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 10 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Dec 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 15 Jul 2025 — OFFICE ACTION ISSUED POU1